ICM
DOCU

Invenomic Capital Management’s DocuSign DOCU Stock Holding History

Invenomic Capital Management’s Portfolio DOCU Stock Details DOCU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-112,189
Closed -$6.97M – 168
2024
Q3 		$6.97M Sell
112,189
-21,764
-16% -$1.22M 0.38% 79
2024
Q2 		$7.17M Buy
+133,953
New +$7.55M 0.35% 84
2024
Q1 		– Sell
-358,881
Closed -$21.3M – 156
2023
Q4 		$21.3M Buy
+358,881
New +$16.5M 0.97% 30

Other funds holding DOCU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
NMO
Newlands Management Operations Dallas, Texas $16.6B AUM 3.91% 1-Year Est. Return

Invenomic Capital Management's DOCU Position: Q4 2024 in Review

Invenomic Capital Management sold out of DocuSign (DOCU) in Q4 2024, closing a stake of 112,189 shares — an estimated $6.97M sold.

Invenomic Capital Management first reported a position in DOCU in Q4 2023 and held it in 3 quarters. The position peaked at $21.3M in Q4 2023. 819 funds tracked by Wall St. Rank hold DOCU as of Q4 2024.

  • Invenomic Capital Management reported no remaining DocuSign position as of Q4 2024 after selling out during the quarter.
  • Invenomic Capital Management sold 112,189 DocuSign shares in Q4 2024, an estimated $6.97M.
  • Invenomic Capital Management first reported a position in DocuSign in Q4 2023 and held it in 3 quarters.
  • Invenomic Capital Management's DocuSign position peaked at $21.3M in Q4 2023.
  • 819 funds tracked by Wall St. Rank held DocuSign as of Q4 2024.

Based on Invenomic Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.